Bridging the Gap from Process Development to CGMP Manufacturing for Gene Therapies

Gene therapy holds the promise of treating the unmet needs of patients who suffer from rare genetic diseases. An estimated 4,000 medical conditions are a result of gene disorders with no established targeted treatments. Gene therapy offers new options away from the conventional symptomatic approach to disease treatment as well as provides hope for real cures.

At Catalent Cell & Gene Therapy, we understand the unique and complex nature of bringing a gene therapy to market, and we are dedicated to achieving the best approach for your product from start to finish. As unique as the therapies themselves are, every path from the bench to the clinic is tailored to ensure that your results are timely and efficient. We are here to optimize your viral development and streamline your manufacturing process for optimal and reliable titers to achieve a stable and effective product dose.

Fill out the form below to read the complete capabilities review about Catalent Cell & Gene Therapy now.